These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 22250063)
1. Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. Curtis PJ; Sampson M; Potter J; Dhatariya K; Kroon PA; Cassidy A Diabetes Care; 2012 Feb; 35(2):226-32. PubMed ID: 22250063 [TBL] [Abstract][Full Text] [Related]
2. Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. Curtis PJ; Potter J; Kroon PA; Wilson P; Dhatariya K; Sampson M; Cassidy A Am J Clin Nutr; 2013 May; 97(5):936-42. PubMed ID: 23553151 [TBL] [Abstract][Full Text] [Related]
3. Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial. Mangano KM; Hutchins-Wiese HL; Kenny AM; Walsh SJ; Abourizk RH; Bruno RS; Lipcius R; Fall P; Kleppinger A; Kenyon-Pesce L; Prestwood KM; Kerstetter JE Nutr Res; 2013 Dec; 33(12):1026-33. PubMed ID: 24267042 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Jayagopal V; Albertazzi P; Kilpatrick ES; Howarth EM; Jennings PE; Hepburn DA; Atkin SL Diabetes Care; 2002 Oct; 25(10):1709-14. PubMed ID: 12351466 [TBL] [Abstract][Full Text] [Related]
5. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Dower JI; Geleijnse JM; Gijsbers L; Zock PL; Kromhout D; Hollman PC Am J Clin Nutr; 2015 May; 101(5):914-21. PubMed ID: 25934864 [TBL] [Abstract][Full Text] [Related]
6. Dietary intakes of flavan-3-ols and cardiometabolic health: systematic review and meta-analysis of randomized trials and prospective cohort studies. Raman G; Avendano EE; Chen S; Wang J; Matson J; Gayer B; Novotny JA; Cassidy A Am J Clin Nutr; 2019 Nov; 110(5):1067-1078. PubMed ID: 31504087 [TBL] [Abstract][Full Text] [Related]
7. The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial. Bazyar H; Moradi L; Zaman F; Zare Javid A Phytother Res; 2023 Jan; 37(1):271-284. PubMed ID: 36101997 [TBL] [Abstract][Full Text] [Related]
8. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Hooper L; Kay C; Abdelhamid A; Kroon PA; Cohn JS; Rimm EB; Cassidy A Am J Clin Nutr; 2012 Mar; 95(3):740-51. PubMed ID: 22301923 [TBL] [Abstract][Full Text] [Related]
9. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Blakesmith SJ; Lyons-Wall PM; George C; Joannou GE; Petocz P; Samman S Br J Nutr; 2003 Apr; 89(4):467-74. PubMed ID: 12654164 [TBL] [Abstract][Full Text] [Related]
10. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905 [TBL] [Abstract][Full Text] [Related]
11. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. Teede HJ; Dalais FS; Kotsopoulos D; Liang YL; Davis S; McGrath BP J Clin Endocrinol Metab; 2001 Jul; 86(7):3053-60. PubMed ID: 11443167 [TBL] [Abstract][Full Text] [Related]
12. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes. Mansour A; Mohajeri-Tehrani MR; Qorbani M; Heshmat R; Larijani B; Hosseini S Nutrition; 2015 Jan; 31(1):119-26. PubMed ID: 25466655 [TBL] [Abstract][Full Text] [Related]
13. Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial. Curtis PJ; van der Velpen V; Berends L; Jennings A; Feelisch M; Umpleby AM; Evans M; Fernandez BO; Meiss MS; Minnion M; Potter J; Minihane AM; Kay CD; Rimm EB; Cassidy A Am J Clin Nutr; 2019 Jun; 109(6):1535-1545. PubMed ID: 31136659 [TBL] [Abstract][Full Text] [Related]
14. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial. Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563 [TBL] [Abstract][Full Text] [Related]
15. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women. Mandrup CM; Egelund J; Nyberg M; Lundberg Slingsby MH; Andersen CB; Løgstrup S; Bangsbo J; Suetta C; Stallknecht B; Hellsten Y Am J Obstet Gynecol; 2017 Apr; 216(4):384.e1-384.e11. PubMed ID: 28024987 [TBL] [Abstract][Full Text] [Related]
16. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Naissides M; Mamo JC; James AP; Pal S Atherosclerosis; 2006 Apr; 185(2):438-45. PubMed ID: 16095600 [TBL] [Abstract][Full Text] [Related]
17. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Scheiber MD; Liu JH; Subbiah MT; Rebar RW; Setchell KD Menopause; 2001; 8(5):384-92. PubMed ID: 11528367 [TBL] [Abstract][Full Text] [Related]
18. Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial. Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ J Womens Health (Larchmt); 2008 Oct; 17(8):1363-9. PubMed ID: 18788990 [TBL] [Abstract][Full Text] [Related]
19. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Moloney F; Yeow TP; Mullen A; Nolan JJ; Roche HM Am J Clin Nutr; 2004 Oct; 80(4):887-95. PubMed ID: 15447895 [TBL] [Abstract][Full Text] [Related]
20. The effects of isoflavones combined with soy protein on lipid profiles, C-reactive protein and cardiovascular risk among postmenopausal Chinese women. Liu ZM; Ho SC; Chen YM; Ho YP Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):712-9. PubMed ID: 21429720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]